Item Type | Name |
Concept
|
Male
|
Academic Article
|
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.
|
Academic Article
|
Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.
|
Academic Article
|
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
|
Academic Article
|
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.
|
Academic Article
|
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
|
Academic Article
|
Diagnosis of unilateral mainstem bronchial obstruction following single-lung transplantation with routine spirometry.
|
Academic Article
|
Radiological versus histological diagnosis in UIP and NSIP: survival implications.
|
Academic Article
|
Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.
|
Academic Article
|
Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation.
|
Academic Article
|
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
|
Academic Article
|
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
|
Academic Article
|
Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.
|
Academic Article
|
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy.
|
Academic Article
|
Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF Study.
|
Academic Article
|
Gender and chronic obstructive pulmonary disease: why it matters.
|
Academic Article
|
A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia.
|
Academic Article
|
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.
|
Academic Article
|
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
|
Academic Article
|
Perspectives of Black Adults Living with Chronic Obstructive Pulmonary Disease on Barriers to Cardiovascular Disease Prevention.
|
Academic Article
|
The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers.
|
Academic Article
|
Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.
|
Academic Article
|
Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid.
|
Academic Article
|
Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.
|
Academic Article
|
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
|
Academic Article
|
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.
|
Academic Article
|
Objectively Measured Chronic Lung Injury?on Chest CT.
|
Academic Article
|
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis.
|
Academic Article
|
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.
|
Academic Article
|
Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study.
|
Academic Article
|
Sex differences in physiological progression of idiopathic pulmonary fibrosis.
|
Academic Article
|
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
|
Academic Article
|
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study.
|
Academic Article
|
Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study.
|
Academic Article
|
Reply to Stowasser et?al.: Assessing How Patients Feel, Function, and Survive in Idiopathic Pulmonary Fibrosis: The Best Is the Enemy of the Good.
|
Academic Article
|
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.
|
Academic Article
|
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis.
|
Academic Article
|
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.
|
Academic Article
|
Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.
|
Academic Article
|
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in?Smokers.
|
Academic Article
|
Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema.
|
Academic Article
|
Clinical significance of radiologic characterizations in COPD.
|
Academic Article
|
Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
|
Academic Article
|
Physiological and computed tomographic predictors of outcome from lung volume reduction surgery.
|
Academic Article
|
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease.
|
Academic Article
|
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.
|
Academic Article
|
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
|
Academic Article
|
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.
|
Academic Article
|
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.
|
Academic Article
|
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.
|
Academic Article
|
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial.
|
Academic Article
|
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD.
|
Academic Article
|
Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients.
|
Academic Article
|
Interstitial lung disease, lung cancer, lung transplantation, pulmonary vascular disorders, and sleep-disordered breathing in AJRCCM in 2004.
|
Academic Article
|
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis.
|
Academic Article
|
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia.
|
Academic Article
|
Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial.
|
Academic Article
|
Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population.
|
Academic Article
|
The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model.
|
Academic Article
|
Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.
|
Academic Article
|
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes.
|
Academic Article
|
Lifetime risk of COPD: what will the future bring?
|
Academic Article
|
A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.
|
Academic Article
|
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Smoking-related idiopathic interstitial pneumonia.
|
Academic Article
|
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.
|
Academic Article
|
Older adults with chronic lung disease report less limitation compared with younger adults with similar lung function impairment.
|
Academic Article
|
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.
|
Academic Article
|
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations.
|
Academic Article
|
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
|
Academic Article
|
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Genome-wide association study of short-acting ?2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.
|
Academic Article
|
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.
|
Academic Article
|
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
|
Academic Article
|
Vessel and Airway Characteristics in One-Year Computed Tomography-defined Rapid Emphysema Progression: SPIROMICS.
|
Academic Article
|
Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease.
|
Academic Article
|
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
|
Academic Article
|
Integrating health status and survival data: the palliative effect of lung volume reduction surgery.
|
Academic Article
|
Outcomes for COPD pharmacological trials: from lung function to biomarkers.
|
Academic Article
|
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE).
|
Academic Article
|
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology.
|
Academic Article
|
Predictors of mortality in patients with emphysema and severe airflow obstruction.
|
Academic Article
|
Predicting pulmonary fibrosis disease course from past trends in pulmonary function.
|
Academic Article
|
The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches.
|
Academic Article
|
Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD.
|
Academic Article
|
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review.
|
Academic Article
|
Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT.
|
Academic Article
|
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis.
|
Academic Article
|
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
|
Academic Article
|
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes.
|
Academic Article
|
Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
|
Academic Article
|
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.
|
Academic Article
|
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).
|
Academic Article
|
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).
|
Academic Article
|
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS.
|
Academic Article
|
Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjects.
|
Academic Article
|
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
|
Academic Article
|
Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
|
Academic Article
|
Racial differences in quality of life in patients with COPD.
|
Academic Article
|
Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial.
|
Academic Article
|
Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.
|
Academic Article
|
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
|
Academic Article
|
GOLD COPD categories are not fit for purpose in primary care--authors' reply.
|
Academic Article
|
Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
|
Academic Article
|
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.
|
Academic Article
|
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting ?2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.
|
Academic Article
|
Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.
|
Academic Article
|
Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?
|
Academic Article
|
Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
|
Academic Article
|
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.
|
Academic Article
|
Baseline values and short serial change: a "road map" for a poor early outcome in idiopathic pulmonary fibrosis.
|
Academic Article
|
Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.
|
Academic Article
|
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
|
Academic Article
|
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
|
Academic Article
|
Azithromycin for prevention of exacerbations of COPD.
|
Academic Article
|
Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
|
Academic Article
|
Cigarette smoking and response to inhaled corticosteroids in COPD.
|
Academic Article
|
The effect of exacerbation history on outcomes in the IMPACT trial.
|
Academic Article
|
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
|
Academic Article
|
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Association between Emphysema and Chronic Obstructive Pulmonary Disease Outcomes in the COPDGene and SPIROMICS Cohorts: A Post Hoc Analysis of Two Clinical Trials.
|
Academic Article
|
Optimizing the 6-min walk test as a measure of exercise capacity in COPD.
|
Academic Article
|
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
|
Academic Article
|
Human airway branch variation and chronic obstructive pulmonary disease.
|
Academic Article
|
Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression.
|
Academic Article
|
Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.
|
Academic Article
|
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
|
Academic Article
|
Update in Chronic Obstructive Pulmonary Disease 2017.
|
Academic Article
|
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.
|
Academic Article
|
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.
|
Academic Article
|
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.
|
Academic Article
|
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
|
Academic Article
|
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.
|
Academic Article
|
Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.
|
Academic Article
|
The role of pulmonary function testing in pulmonary fibrosis.
|
Academic Article
|
Host, Gender, and Early-Life Factors as Risks for Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs.
|
Academic Article
|
Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.
|
Academic Article
|
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort.
|
Academic Article
|
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials.
|
Academic Article
|
Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort.
|
Academic Article
|
The clinical impact of non-obstructive chronic bronchitis in current and former smokers.
|
Academic Article
|
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
|
Academic Article
|
Chronic obstructive pulmonary disease subpopulations and phenotyping.
|
Academic Article
|
Update in diffuse parenchymal lung diseases 2005.
|
Academic Article
|
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
|
Academic Article
|
Analysis of the lung microbiome in the "healthy" smoker and in COPD.
|
Academic Article
|
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
|
Academic Article
|
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
|
Academic Article
|
Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers.
|
Academic Article
|
Obligatory role for interleukin-13 in obstructive lesion development in airway allografts.
|
Academic Article
|
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
|
Academic Article
|
Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease.
|
Academic Article
|
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers.
|
Academic Article
|
Long-acting bronchodilators in COPD: an evolving story.
|
Academic Article
|
Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia.
|
Academic Article
|
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
|
Academic Article
|
Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease.
|
Academic Article
|
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
|
Academic Article
|
An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup.
|
Academic Article
|
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.
|
Academic Article
|
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
|
Academic Article
|
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.
|
Academic Article
|
Internet access and use by COPD patients in the National Emphysema/COPD Association Survey.
|
Academic Article
|
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene.
|
Academic Article
|
A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
|
Academic Article
|
Latent traits of lung tissue patterns in former smokers derived by dual channel deep learning in computed tomography images.
|
Academic Article
|
Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Effects of baseline symptom burden on treatment response in COPD.
|
Academic Article
|
The influence of social support on COPD outcomes mediated by depression.
|
Academic Article
|
Surgical therapy for chronic obstructive pulmonary disease.
|
Academic Article
|
Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS).
|
Academic Article
|
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
|
Academic Article
|
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.
|
Academic Article
|
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
|
Academic Article
|
TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Metoprolol for the Prevention of Acute Exacerbations of COPD.
|
Academic Article
|
Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
|
Academic Article
|
Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema.
|
Academic Article
|
Pulmonary arterial enlargement and acute exacerbations of COPD.
|
Academic Article
|
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.
|
Academic Article
|
CT metrics of airway disease and emphysema in severe COPD.
|
Academic Article
|
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.
|
Academic Article
|
The microbiota in respiratory disease.
|
Academic Article
|
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.
|
Academic Article
|
Longitudinal change in the BODE index predicts mortality in severe emphysema.
|
Academic Article
|
Prevalence and clinical correlates of bronchoreversibility in severe emphysema.
|
Academic Article
|
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
|
Academic Article
|
The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS.
|
Academic Article
|
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey.
|
Academic Article
|
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
|
Academic Article
|
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression.
|
Academic Article
|
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.
|
Academic Article
|
Gender influences Health-Related Quality of Life in IPF.
|
Academic Article
|
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
|
Academic Article
|
Genetic association analysis of functional impairment in chronic obstructive pulmonary disease.
|
Academic Article
|
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS).
|
Academic Article
|
Variability in objective and subjective measures affects baseline values in studies of patients with COPD.
|
Academic Article
|
Relationship between diffusion capacity and small airway abnormality in COPDGene.
|
Academic Article
|
Respiratory response during arm elevation in isolated diaphragm weakness.
|
Academic Article
|
Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease.
|
Academic Article
|
Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial.
|
Academic Article
|
Temporal Exploration of Chronic Obstructive Pulmonary Disease Phenotypes: Insights from the COPDGene and SPIROMICS Cohorts.
|
Academic Article
|
Weight gain after lung volume reduction surgery is not correlated with improvement in pulmonary mechanics.
|
Academic Article
|
Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease.
|
Academic Article
|
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS.
|
Academic Article
|
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function.
|
Academic Article
|
Airway Mucin Concentration as a Marker of Chronic Bronchitis.
|
Academic Article
|
Lung CD8+ T cells in COPD have increased expression of bacterial TLRs.
|
Academic Article
|
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement.
|
Academic Article
|
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease.
|
Academic Article
|
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study.
|
Academic Article
|
Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.
|
Academic Article
|
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.
|
Academic Article
|
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction.
|
Academic Article
|
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
|
Academic Article
|
Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.
|
Academic Article
|
Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.
|
Academic Article
|
Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.
|
Academic Article
|
Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.
|
Academic Article
|
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.
|
Academic Article
|
Long-Acting ?-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial.
|
Academic Article
|
Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.
|
Academic Article
|
Surgical patient outcomes after the increased use of bilateral lung transplantation.
|
Academic Article
|
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
|
Academic Article
|
Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial.
|
Academic Article
|
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab.
|
Academic Article
|
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial.
|
Academic Article
|
Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
|
Academic Article
|
Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts.
|
Academic Article
|
Genetic determinants of emphysema distribution in the national emphysema treatment trial.
|
Academic Article
|
Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations.
|
Academic Article
|
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia.
|
Academic Article
|
Identification of a unique temporal signature in blood and BAL associated with IPF progression.
|
Academic Article
|
Sex differences in severe pulmonary emphysema.
|
Academic Article
|
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
|
Academic Article
|
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.
|
Academic Article
|
Spirometry utilization for COPD: how do we measure up?
|
Academic Article
|
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved?Spirometry in SPIROMICS.
|
Academic Article
|
Prediction of acute respiratory disease in current and former smokers with and without COPD.
|
Academic Article
|
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
|
Academic Article
|
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
|
Academic Article
|
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
|
Academic Article
|
Effect of daily azithromycin therapy and adherence on readmission risk in COPD.
|
Academic Article
|
Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy.
|
Academic Article
|
Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.
|
Academic Article
|
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
|